About
Pronto Diagnostics develops, produces, and distributes genetic testing kits that provide rapid and accurate assays for detecting polymorphisms in DNA sequences associated with genetic diseases and predisposition to disease. The company's kits, which test for more than 35 different DNA variants, are suitable for both small-scale and large-scale clinical genetic analysis. The kits meet the highest international quality production standards and have all received the European CE mark. In the complete genotyping format of the Pronto system, each mutation site is tested in two wells of a 96-well microtiter plate. Every sample is separately and internally controlled for each mutation tested. Results are clearly determined visually as well as analyzed by a standard ELISA reader. Pronto Diagnostics performs all operating and commercial activities for Aferrix, a diagnostic start-up specializing in the analysis of plasma iron levels.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Pronto Diagnostics acquired and by which company?
- Pronto Diagnostics was acquired by Novolog Group in October 2022.
- What is the primary focus of Pronto Diagnostics' products?
- Pronto Diagnostics develops, produces, and distributes genetic testing kits for the clinical diagnosis of genetic diseases by detecting polymorphisms in DNA sequences.
- How many different DNA variants can Pronto Diagnostics' kits test for?
- Pronto Diagnostics' kits can test for more than 35 different DNA variants.
- What international quality standard do Pronto Diagnostics' kits meet?
- Pronto Diagnostics' kits have received the European CE mark, indicating they meet international quality production standards.
- What is the operational relationship between Pronto Diagnostics and Aferrix?
- Pronto Diagnostics performs all operating and commercial activities for Aferrix, a diagnostic startup specializing in the analysis of plasma iron levels.
- When was Pronto Diagnostics founded?
- Pronto Diagnostics was founded in July 1993.
- What was the reported acquisition amount for 75% of Pronto Diagnostics by Novolog Group?
- Novolog Group acquired 75% of Pronto Diagnostics for approximately ILS 11 million in October 2022.
- What partnership did Pronto Diagnostics announce in July 2018?
- In July 2018, Pronto Diagnostics partnered with MNG Laboratories to offer clinical RNA sequencing services in Israel.
- What integration did Pronto Diagnostics plan in March 2018?
- In March 2018, Pronto Diagnostics planned to integrate FDNA's phenotypic analysis into its genetic tests.